BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 33684053)

  • 1. Clinical Trial Data Sharing for COVID-19-Related Research.
    Dron L; Dillman A; Zoratti MJ; Haggstrom J; Mills EJ; Park JJH
    J Med Internet Res; 2021 Mar; 23(3):e26718. PubMed ID: 33684053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timely access to trial data in the context of a pandemic: the time is now.
    Li R; Wood J; Baskaran A; Neumann S; Graham E; Levenstein M; Sim I
    BMJ Open; 2020 Oct; 10(10):e039326. PubMed ID: 33122319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19: a pandemic experience that illuminates potential reforms to health research.
    Kozlowski HN; Farkouh ME; Irwin MS; Radvanyi LG; Schimmer AD; Tabori U; Rosenblum ND
    EMBO Mol Med; 2020 Nov; 12(11):e13278. PubMed ID: 32996267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials and the COVID-19 pandemic.
    Retsas S
    Hell J Nucl Med; 2020; 23(1):4-5. PubMed ID: 32361715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management and Data Sharing of COVID-19 Pandemic Information.
    Gao F; Tao L; Huang Y; Shu Z
    Biopreserv Biobank; 2020 Dec; 18(6):570-580. PubMed ID: 33320734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea.
    Jeon J; Kim H; Yu KS
    J Korean Med Sci; 2020 Sep; 35(36):e329. PubMed ID: 32924344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 trials: declarations of data sharing intentions at trial registration and at publication.
    Li R; von Isenburg M; Levenstein M; Neumann S; Wood J; Sim I
    Trials; 2021 Feb; 22(1):153. PubMed ID: 33602275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. It is unprecedented: trial management during the COVID-19 pandemic and beyond.
    Mitchell EJ; Ahmed K; Breeman S; Cotton S; Constable L; Ferry G; Goodman K; Hickey H; Meakin G; Mironov K; Quann N; Wakefield N; McDonald A
    Trials; 2020 Sep; 21(1):784. PubMed ID: 32917258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis.
    Mehta HB; Ehrhardt S; Moore TJ; Segal JB; Alexander GC
    BMJ Open; 2020 Jun; 10(6):e039978. PubMed ID: 32518212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reporting and design of randomized controlled trials for COVID-19: A systematic review.
    Dillman A; Park JJH; Zoratti MJ; Zannat NE; Lee Z; Dron L; Hsu G; Smith G; Khakabimamaghani S; Harari O; Thorlund K; Mills EJ
    Contemp Clin Trials; 2021 Feb; 101():106239. PubMed ID: 33279656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving effective informed oversight by DMCs in COVID clinical trials.
    DeMets DL; Fleming TR
    J Clin Epidemiol; 2020 Oct; 126():167-171. PubMed ID: 32659363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 hits a trial: Arguments against hastily deviating from the plan.
    Großhennig A; Koch A
    Contemp Clin Trials; 2020 Nov; 98():106155. PubMed ID: 32961360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analytical and Clinical Analysis of Two Automated Anti-SARS-CoV-2 Immunoassays in Pre-Pandemic and Pandemic Patient Populations.
    Yang J; Pederson EC; Hamilton C; Neibauer T; Robyak K; McGhee P; Speicher T; Zhu Y
    J Appl Lab Med; 2021 Mar; 6(2):441-450. PubMed ID: 33152084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balancing clinical evidence in the context of a pandemic.
    Adashek JJ; Kurzrock R
    Nat Biotechnol; 2021 Mar; 39(3):270-274. PubMed ID: 33547424
    [No Abstract]   [Full Text] [Related]  

  • 17. SARS-CoV-2 Surveillance in the Middle East and North Africa: Longitudinal Trend Analysis.
    Post L; Marogi E; Moss CB; Murphy RL; Ison MG; Achenbach CJ; Resnick D; Singh L; White J; Boctor MJ; Welch SB; Oehmke JF
    J Med Internet Res; 2021 Jan; 23(1):e25830. PubMed ID: 33302252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 predictability in the United States using Google Trends time series.
    Mavragani A; Gkillas K
    Sci Rep; 2020 Nov; 10(1):20693. PubMed ID: 33244028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 interventional trials: Analysis of data sharing intentions during a time of pandemic.
    Larson K; Sim I; von Isenburg M; Levenstein M; Rockhold F; Neumann S; D'Arcy C; Graham E; Zuckerman D; Li R
    Contemp Clin Trials; 2022 Apr; 115():106709. PubMed ID: 35182738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A need for open public data standards and sharing in light of COVID-19.
    Gardner L; Ratcliff J; Dong E; Katz A
    Lancet Infect Dis; 2021 Apr; 21(4):e80. PubMed ID: 32791042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.